Session(s)
- Current Diagnostic Criteria Are Unable to Classify a High Proportion of Patients in a Card...
Sunday, May 20 9:15 AM - 11:15 AM - Safety and Suitability of a Direct Thrombin Inhibitor, Dabigatran Etexilate, in Scleroderm...
Sunday, May 20 9:15 AM - 11:15 AM - Physical Activity Measured by an Accelerometer to Monitor Patients with Pulmonary Arterial...
Sunday, May 20 11:15 AM - 1:00 PM - Short-Term Cardiovascular Effects of Low Dose Carvedilol in Pulmonary Hypertension
Monday, May 21 11:00 AM - 11:15 AM - Baseline and Demographic Data on the First 250 Patients from SPHERE (UptraviĀ® [SelexiPag]:...
Tuesday, May 22 11:15 AM - 1:00 PM - Transitions from Inhaled, Intravenous, Subcutaneous, or Oral Prostacyclins to Selexipag: I...
Tuesday, May 22 11:15 AM - 1:00 PM - CLINICOPATHOLOGIC CORRELATION OF AUTOIMMUNE DISORDERS-ASSOCIATED LUNG DISEASE
Tuesday, May 22 12:15 PM - 1:15 PM - Real-World Dosing and Titration of Selexipag in Patients with Pulmonary Arterial Hypertens...
Wednesday, May 23 1:30 PM - 3:30 PM